Amedeo Smart

Free Medical Literature Service


 

Amedeo

Stem Cell Research

  Free Subscription

Articles published in
Gene Ther
    November 2023
  1. KOHN DB, Chen YY, Spencer MJ
    Successes and challenges in clinical gene therapy.
    Gene Ther. 2023;30.
    >> Share

    October 2023
  2. ZHU D, Barabadi M, McDonald C, Kusuma G, et al
    Implications of maternal-fetal health on perinatal stem cell banking.
    Gene Ther. 2023 Oct 26. doi: 10.1038/s41434-023-00426.
    >> Share

    August 2023
  3. BELL JA, Collon K, Mayfield C, Gallo MC, et al
    Biodistribution of lentiviral transduced adipose-derived stem cells for "ex-vivo" regional gene therapy for bone repair.
    Gene Ther. 2023 Aug 11. doi: 10.1038/s41434-023-00415.
    >> Share

    April 2023
  4. MIRJALILI MOHANNA SZ, Korecki AJ, Simpson EM
    rAAV-PHP.B escapes the mouse eye and causes lethality whereas rAAV9 can transduce aniridic corneal limbal stem cells without lethality.
    Gene Ther. 2023 Apr 19. doi: 10.1038/s41434-023-00400.
    >> Share

  5. SAGOO P, Gaspar HB
    The transformative potential of HSC gene therapy as a genetic medicine.
    Gene Ther. 2023;30.
    >> Share

    March 2023
  6. TOMINAGA S, Ojima T, Miyazawa M, Iwamoto H, et al
    Induced pluripotent stem cell-derived dendritic cell vaccine therapy genetically modified on the ubiquitin-proteasome system.
    Gene Ther. 2023 Mar 23. doi: 10.1038/s41434-023-00388.
    >> Share

    December 2022
  7. SULEMAN S, Payne A, Bowden J, Haque SA, et al
    HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival.
    Gene Ther. 2022;29:720-729.
    >> Share

  8. AIT BENICHOU S, Jauvin D, De Serres-Berard T, Pierre M, et al
    Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1.
    Gene Ther. 2022;29:698-709.
    >> Share

    October 2022
  9. COLLON K, Bell JA, Gallo MC, Chang SW, et al
    Influence of donor age and comorbidities on transduced human adipose-derived stem cell in vitro osteogenic potential.
    Gene Ther. 2022 Oct 11. pii: 10.1038/s41434-022-00367.
    >> Share

    July 2022
  10. SHIMADA Y, Ishii N, Higuchi T, Goto M, et al
    A novel preclinical model of mucopolysaccharidosis type II for developing human hematopoietic stem cell gene therapy.
    Gene Ther. 2022 Jul 14. pii: 10.1038/s41434-022-00357.
    >> Share

    February 2022
  11. LIANG G, Qin Z, Luo Y, Yin J, et al
    Exosomal microRNA-133b-3p from bone marrow mesenchymal stem cells inhibits angiogenesis and oxidative stress via FBN1 repression in diabetic retinopathy.
    Gene Ther. 2022 Feb 7. pii: 10.1038/s41434-021-00310.
    >> Share

    December 2021
  12. BOUGIOUKLI S, Chateau M, Morales H, Vakhshori V, et al
    Limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications.
    Gene Ther. 2021;28:729-739.
    >> Share

    June 2021
  13. SWEENEY CL, Pavel-Dinu M, Choi U, Brault J, et al
    Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair.
    Gene Ther. 2021;28:373-390.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016